Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)

China · Delayed Price · Currency is CNY

5.55

+0.11 (2.02%)

Jul 31, 2026, 3:05 PM CST

SHE:000952 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	638.58	623.97	638.8	737.82	797.64	785.57
Revenue Growth	5.18%	-2.32%	-13.42%	-7.50%	1.54%	14.15%
Gross Profit	134.38	140.77	114.03	187.93	287.42	298.15
Operating Income	-143.98	-153.28	-217.04	-94.7	51.13	87.28
Net Income	-399.87	-404.49	-295.29	-140.25	50.33	110.11
Earnings Per Share	-1.15	-1.16	-0.84	-0.40	0.14	0.32
EPS Growth	-	-	-	-	-55.42%	43.41%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
domestic	404.97	388.7	555.69	580.84	479.81
Foreign	219	250.1	182.13	216.8	305.77
Total	623.97	638.8	737.82	797.64	785.57

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	329.05	278.49	307.18	415.24	431.35	293.33
Total Debt	709.93	960.99	873.19	873.69	662	378.26
Net Cash (Debt)	-380.87	-682.5	-566.01	-458.45	-230.65	-84.93
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.10	-1.96	-1.61	-1.30	-0.65	-0.25

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	93.79	60.43	0.66	-148.96	45.08	75.91
Capital Expenditures	-30.81	-35.64	-154.93	-566.13	-203.71	-96.61
Free Cash Flow	62.98	24.79	-154.28	-715.1	-158.63	-20.7
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	21.04%	22.56%	17.85%	25.47%	36.03%	37.95%
Operating Margin	-22.55%	-24.57%	-33.98%	-12.83%	6.41%	11.11%
Pretax Margin	-68.47%	-71.01%	-50.14%	-19.07%	7.53%	15.83%
Profit Margin	-62.62%	-64.83%	-46.23%	-19.01%	6.31%	14.02%
FCF Margin	9.86%	3.97%	-24.15%	-96.92%	-19.89%	-2.63%

Dividends

Fiscal Year	FY 2021
Period Ending	Jan '22 Jan 1, 2022
Dividend Per Share	0.060
Dividend Per Share Growth	0%
Dividend Yield	0.77%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	-	-	53.87	24.46
Forward PE	-	5.34	5.34	5.34	5.34	5.34
P/FCF Ratio	30.56	98.34	-	-	-	-
PS Ratio	3.01	3.91	3.39	3.83	3.40	3.43